Literature DB >> 33405357

Clinical features of homozygous FIG4-p.Ile41Thr Charcot-Marie-Tooth 4J patients.

Maxime Lafontaine1, Anne-Sophie Lia1,2,3, Sylvie Bourthoumieu4, Hélène Beauvais-Dzugan1,2, Paco Derouault4, Marie-Christine Arné-Bes5, Catherine Sarret6, Fanny Laffargue6, Armelle Magot7, Franck Sturtz1,2, Laurent Magy2,8, Corinne Magdelaine1,2.   

Abstract

We describe the clinical, electrodiagnostic, and genetic findings of three homozygous FIG4-c.122T>C patients suffering from Charcot-Marie-Tooth disease type 4J (AR-CMT-FIG4). This syndrome usually involves compound heterozygosity associating FIG4-c.122T>C, a hypomorphic allele coding an unstable FIG4-p.Ile41Thr protein, and a null allele. While the compound heterozygous patients presenting with early onset usually show rapid progression, the homozygous patients described here show the signs of relative clinical stability. As FIG4 activity is known to be dose dependent, these patients' observations could suggest that the therapeutic perspective of increasing levels of the protein to improve the phenotype of AR-CMT-FIG4-patients might be efficient.
© 2021 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association.

Entities:  

Year:  2021        PMID: 33405357     DOI: 10.1002/acn3.51175

Source DB:  PubMed          Journal:  Ann Clin Transl Neurol        ISSN: 2328-9503            Impact factor:   4.511


  2 in total

Review 1.  Roles of PIKfyve in multiple cellular pathways.

Authors:  Pilar Rivero-Ríos; Lois S Weisman
Journal:  Curr Opin Cell Biol       Date:  2022-05-16       Impact factor: 8.386

2.  Clinical and Genetic Analysis of a Patient with CMT4J.

Authors:  Leema Reddy Peddareddygari; Raji P Grewal
Journal:  Neurol Int       Date:  2022-02-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.